Danielle Libersan

1.1k total citations
10 papers, 517 citations indexed

About

Danielle Libersan is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Immunology and Allergy. According to data from OpenAlex, Danielle Libersan has authored 10 papers receiving a total of 517 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cardiology and Cardiovascular Medicine, 6 papers in Surgery and 3 papers in Immunology and Allergy. Recurrent topics in Danielle Libersan's work include Antiplatelet Therapy and Cardiovascular Diseases (3 papers), Cell Adhesion Molecules Research (3 papers) and Cardiac and Coronary Surgery Techniques (3 papers). Danielle Libersan is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (3 papers), Cell Adhesion Molecules Research (3 papers) and Cardiac and Coronary Surgery Techniques (3 papers). Danielle Libersan collaborates with scholars based in Canada and France. Danielle Libersan's co-authors include Yahye Merhi, Pierre R. Richard, Kristian B. Filion, Mark J. Eisenberg, Hani Sinno, Tack Ki Leung, Katayoun Derakhchan, Stanley Nattel, Guy Rousseau and Anjali Kumar and has published in prestigious journals such as Circulation, Cardiovascular Research and European Journal of Pharmacology.

In The Last Decade

Danielle Libersan

10 papers receiving 500 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Danielle Libersan Canada 8 391 152 55 52 50 10 517
Bernadeta Chyrchel Poland 10 196 0.5× 61 0.4× 32 0.6× 91 1.8× 17 0.3× 38 322
Athanasios Karathanos Germany 13 234 0.6× 127 0.8× 43 0.8× 30 0.6× 61 1.2× 32 449
Pei Zhu China 12 162 0.4× 79 0.5× 51 0.9× 92 1.8× 7 0.1× 46 396
Roberta Paliotti Italy 12 289 0.7× 122 0.8× 47 0.9× 99 1.9× 3 0.1× 28 498
Carmen Cristóbal Spain 12 214 0.5× 114 0.8× 47 0.9× 83 1.6× 5 0.1× 44 438
V. А. Snezhitskiy Belarus 5 404 1.0× 63 0.4× 31 0.6× 123 2.4× 22 0.4× 54 582
Tetsuo Horimatsu Japan 12 148 0.4× 277 1.8× 172 3.1× 40 0.8× 25 0.5× 46 452
P A Merlini Italy 4 388 1.0× 126 0.8× 65 1.2× 33 0.6× 160 3.2× 6 520
C. W. Jackson United States 10 47 0.1× 50 0.3× 102 1.9× 70 1.3× 18 0.4× 12 473
Jessica Mann Switzerland 5 238 0.6× 149 1.0× 26 0.5× 94 1.8× 50 1.0× 6 401

Countries citing papers authored by Danielle Libersan

Since Specialization
Citations

This map shows the geographic impact of Danielle Libersan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danielle Libersan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danielle Libersan more than expected).

Fields of papers citing papers by Danielle Libersan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danielle Libersan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danielle Libersan. The network helps show where Danielle Libersan may publish in the future.

Co-authorship network of co-authors of Danielle Libersan

This figure shows the co-authorship network connecting the top 25 collaborators of Danielle Libersan. A scholar is included among the top collaborators of Danielle Libersan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Danielle Libersan. Danielle Libersan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Eisenberg, Mark J., Pierre R. Richard, Danielle Libersan, & Kristian B. Filion. (2009). Safety of Short-Term Discontinuation of Antiplatelet Therapy in Patients With Drug-Eluting Stents. Circulation. 119(12). 1634–1642. 162 indexed citations
2.
Tanguay, Jean‐François, Pierre A. Geoffroy, Martin G. Sirois, et al.. (2004). Prevention of in-stent restenosis via reduction of thrombo-inflammatory reactions with recombinant P-selectin glycoprotein ligand-1. Thrombosis and Haemostasis. 91(6). 1186–1193. 39 indexed citations
3.
Libersan, Danielle & Yahye Merhi. (2003). Platelet P-selectin expression: requirement for protein kinase C, but not protein tyrosine kinase or phosphoinositide 3-kinase. Thrombosis and Haemostasis. 89(6). 1016–1023. 11 indexed citations
4.
Sinno, Hani, Katayoun Derakhchan, Danielle Libersan, et al.. (2003). Atrial Ischemia Promotes Atrial Fibrillation in Dogs. Circulation. 107(14). 1930–1936. 202 indexed citations
5.
Libersan, Danielle, Guy Rousseau, & Yahye Merhi. (2003). Differential regulation of P-selectin expression by protein kinase A and protein kinase G in thrombin-stimulated human platelets. Thrombosis and Haemostasis. 89(2). 310–317. 23 indexed citations
6.
Libersan, Danielle, et al.. (1999). Intravenous Aspirin at Reperfusion Does Not Reduce Infarct Size in the Dog with a Residual Critical Stenosis. Journal of Cardiovascular Pharmacology. 34(4). 575–583. 7 indexed citations
7.
Libersan, Danielle. (1998). The low molecular weight heparin, enoxaparin, limits infarct size at reperfusion in the dog. Cardiovascular Research. 37(3). 656–666. 42 indexed citations
8.
Libersan, Danielle, R. Marchand, S Montplaisir, C Chartrand, & Louis Dumont. (1997). Cardioprotective Effects of Diltiazem during Acute Rejection on Heterotopic Heart Transplants. European Surgical Research. 29(3). 229–236. 7 indexed citations
9.
Rousseau, Guy, et al.. (1993). Importance of platelets in myocardial injury after reperfusion in the presence of residual coronary stenosis in dogs. American Heart Journal. 125(6). 1553–1563. 22 indexed citations
10.
Dumont, Louis, Danielle Libersan, C Chartrand, E Lévy, & D. Garceau. (1990). Inhibition of platelet aggregation by a new 1.5-benzothiazepine calcium antagonist, TA-3090. European Journal of Pharmacology. 183(2). 638–638. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026